Wall Street’s Week Plagued by Higher Bond Yields
...
31May
Read more...
31May
Pfizer lung cancer drug shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment for the condition.The company's medicine helped patients live longer without seeing their cancer progress, and most...
31May
Read more...
31May
First quarter retail earnings don’t spell consumer comeback
Shoppers at a shopping center in Birmingham, United Kingdom, on February 11, 2024. Nurphoto | Nurphoto | Getty ImagesRetail's biggest winners during first-quarter earnings aren't thriving because consumers are suddenly spending more on discretionary goods – it's because they're executing well and cash-strapped shoppers are choosing them over competitors. If there's...
31May
Stocks making the biggest moves midday: GPS, MDB, DELL
Check out the companies making headlines in midday trading. Dell Technologies — The software stock plunged 22% after executives cautioned that its gross margins could face more pressure in 2025. Lionsgate Studios — Shares rose 1% after Citi initiated coverage of the film studio at a buy rating. The...
31May
Warren Buffett worried about ‘huge losses’ in booming insurance market
One of the messages that Warren Buffett and Berkshire Hathaway's top insurance executive, Ajit Jain, sent to investors during the company's annual shareholder meeting in Omaha last month was that cyber insurance, while currently profitable, still has too many unknowns and risks for Berkshire, a huge player in the...
31May
FDA approves Moderna RSV vaccine for seniors
Nikos Pekiaridis | Lightrocket | Getty ImagesThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial virus for adults ages 60 and above, the company's second-ever product to enter the U.S. market. The decision is a win for Moderna, which desperately needs another revenue source amid plunging...
31May
Aston Martin gets a boost from Formula 1, new models
With a parade of new models and a marketing tailwind from Formula 1, sports car maker Aston Martin expects to become cash-flow positive this year, according to executive chairman Lawrence Stroll."We're now at a really transitional moment, with an inflection point for this company," Stroll told CNBC. "We're introducing...
31May
Read more...
31May
Read more...